Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
263.5 SEK | +3.33% | -0.38% | +24.29% |
Apr. 25 | Transcript : CellaVision AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 25 | CellaVision AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 782M 73.97M | Sales 2025 * | 889M 84M | Capitalization | 6.08B 575M |
---|---|---|---|---|---|
Net income 2024 * | 172M 16.26M | Net income 2025 * | 217M 20.52M | EV / Sales 2024 * | 7.6 x |
Net cash position 2024 * | 138M 13.01M | Net cash position 2025 * | 212M 20.07M | EV / Sales 2025 * | 6.61 x |
P/E ratio 2024 * |
35.5
x | P/E ratio 2025 * |
28
x | Employees | - |
Yield 2024 * |
0.97% | Yield 2025 * |
1.18% | Free-Float | 82.65% |
Latest transcript on CellaVision AB
1 day | +0.39% | ||
1 week | +4.72% | ||
Current month | +13.08% | ||
1 month | +15.65% | ||
3 months | -1.35% | ||
6 months | +45.88% | ||
Current year | +20.28% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 59 | 94-11-15 | |
Simon Ostergaard
CEO | Chief Executive Officer | 53 | 21-03-20 |
Magnus Blixt
DFI | Director of Finance/CFO | 58 | 13-05-01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 59 | 94-11-15 | |
Lotta Jarleryd
BRD | Director/Board Member | 58 | 22-05-10 |
Mikael Worning
CHM | Chairman | 62 | 20-04-22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-28 | 263.5 | +3.33% | 17 241 |
24-05-27 | 255 | +0.39% | 10,147 |
24-05-24 | 254 | +0.59% | 5,059 |
24-05-23 | 252.5 | -5.08% | 9,653 |
24-05-22 | 266 | +0.57% | 23,339 |
Delayed Quote Nasdaq Stockholm, May 27, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.28% | 573M | |
-23.89% | 17.05B | |
-42.47% | 2.84B | |
+17.00% | 1.85B | |
-6.24% | 1.56B | |
+34.78% | 1.36B | |
-19.86% | 924M | |
-25.21% | 856M | |
+7.22% | 841M | |
-27.85% | 604M |
- Stock Market
- Equities
- CEVI Stock